Clinical trials recruiting in Multiple Locations, Japan

Phase breakdown

Conditions recruiting in Multiple Locations, Japan

Recruiting trials in Multiple Locations, Japan

• A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
  NCT06661122 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
  NCT05666518 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
  NCT06278207 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
  NCT04519619 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Multiple Locations, Japan?

4 recruiting trials have at least one study site in Multiple Locations, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.